MedMiraDec 21, 20211 minMDSAP Certification We are delighted to announce the receipt of the MDSAP certificate today. This highlights our firm and long lasting commitment to the...
MedMiraDec 17, 20213 minMedMira strengthen its Board with New AppointmentHalifax, Nova Scotia, 17 December 2021 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announced today the appointment of Mr. Thomas Bergmann...
MedMiraDec 14, 20212 minMedMira announces significant debt reduction and additional growth capitalHalifax, Nova Scotia, 14 December, 2021 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces a financial package of over $5.23 million...
MedMiraDec 10, 20211 minSay Hello to VYRA CoV2Flu! Your answer to "Flurona"..We are excited to introduce our latest product: VYRA CoV2Flu Rapid Antigen Test Quality, Speed, Ease-of-Use and Design combined - only...
MedMiraJun 14, 20212 minPerformance Update on World Health Organisation SARS-CoV2 Serology StandardsHalifax, Nova Scotia, 14 June, 2021 – MedMira Inc. (MedMira) (TSXV: MIR) announces the World Health Organization (WHO) SARS-CoV-2...
MedMiraMar 3, 20212 minProduct and Regulatory Update on MedMira’s COVID-19 Product FamilyHalifax, Nova Scotia, 03 March, 2021 – MedMira Inc. (MedMira) (TSXV: MIR) announces the expansion of its product portfolio and outlines...